CD133 expression in patients with peripheral neuroblastic tumor: a systematic review
Introduction: Neuroblastoma is known as one of the most common solid tumors in children, which is recently under the investigation for the expression of CD133, a marker of cancer stem cells. Revealing the prognostic value of CD133 marker expression is important in predicting the outcome and survival...
Main Authors: | Hedieh Nazarzadeh, Yavar Shams Hojati, Reza Nazarzadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2015-10-01
|
Series: | Reviews in Clinical Medicine |
Subjects: | |
Online Access: | https://rcm.mums.ac.ir/article_4716_22c561b6a78511782b48f56d3f8e3382.pdf |
Similar Items
-
CD133 expression in patients with peripheral neuroblastic tumor: a systematic review
by: Hedieh Nazarzadeh, et al.
Published: (2015-09-01) -
Molecular Regulation of Autophagy and Asymmetric Cell Division by Cancer Stem Cell Marker CD133
by: Hideki Izumi, et al.
Published: (2023-03-01) -
Prostate Cancer Stem Cells: The Role of CD133
by: Jianhui Yang, et al.
Published: (2022-11-01) -
Significance of CD133 Expression in Invasive Ductal Carcinoma of the Breast
by: Nagwa Abd El-Sadek Ahmed, et al.
Published: (2022-02-01) -
The Utilization and Limitation of CD133 Epitopes in Lung Cancer Stem Cells Research
by: Yin CHEN, et al.
Published: (2011-10-01)